Ftse Mib
34.226,22
1,04%
DAX
18.497,88
0,68%
S&P 500
5.375,32
0,27%
NASDAQ
17.343,55
0,00%
Bitcoin
67.837,80
0,76%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Baudax Bio Inc (BXRX) Baudax Bio Inc (BXRX) Notizie

BXRX

Baudax Bio (BXRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BXRX
DataOraFonteTitoloSimboloCompagnia
15/11/202323:25Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BXRXBaudax Bio Inc
15/11/202322:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
11/10/202322:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BXRXBaudax Bio Inc
10/10/202313:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
26/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BXRXBaudax Bio Inc
21/09/202323:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BXRXBaudax Bio Inc
21/09/202322:48Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BXRXBaudax Bio Inc
07/09/202323:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BXRXBaudax Bio Inc
07/09/202322:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BXRXBaudax Bio Inc
05/09/202323:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BXRXBaudax Bio Inc
25/08/202322:01Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:BXRXBaudax Bio Inc
24/08/202323:05Edgar (US Regulatory)Form 8-A12G - Registration of securities [Section 12(g)]NASDAQ:BXRXBaudax Bio Inc
18/08/202322:40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BXRXBaudax Bio Inc
17/08/202314:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BXRXBaudax Bio Inc
31/07/202322:48Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BXRXBaudax Bio Inc
28/06/202323:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BXRXBaudax Bio Inc
27/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BXRXBaudax Bio Inc
05/06/202322:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BXRXBaudax Bio Inc
11/05/202323:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BXRXBaudax Bio Inc
28/04/202322:37Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BXRXBaudax Bio Inc
28/04/202322:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BXRXBaudax Bio Inc
06/04/202322:13Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BXRXBaudax Bio Inc
23/02/202314:50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BXRXBaudax Bio Inc
14/02/202318:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BXRXBaudax Bio Inc
24/01/202314:00GlobeNewswire Inc.Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000NASDAQ:BXRXBaudax Bio Inc
08/12/202214:00GlobeNewswire Inc.Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing SurgeryNASDAQ:BXRXBaudax Bio Inc
07/12/202214:35TipRanksNoble Financial Keeps Their Buy Rating on Baudax Bio (BXRX)NASDAQ:BXRXBaudax Bio Inc
06/12/202222:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BXRXBaudax Bio Inc
06/12/202222:11GlobeNewswire Inc.Baudax Bio Announces Closing of $5 Million Public OfferingNASDAQ:BXRXBaudax Bio Inc
05/12/202212:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BXRXBaudax Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BXRX

La tua Cronologia

BIT
SPM
Saipem
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
LDO
Leonardo
BIT
TIT
Telecom Italia
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network